Compounds > 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
Page last updated: 2024-10-26

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Adenocarcinoma

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Adenocarcinoma in 1 studies

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gouazé, V1
Liu, YY1
Prickett, CS1
Yu, JY1
Giuliano, AE1
Cabot, MC1

Other Studies

1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Adenocarcinoma

ArticleYear
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Cancer research, 2005, May-01, Volume: 65, Issue:9

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line

2005